Malignant-Hyperthermia Susceptibility Is Associated with a Mutation of the a1-Subunit of the Human Dihydropyridine-Sensitive L-Type Voltage-Dependent Calcium-Channel Receptor in Skeletal Muscle

This publication has 51 references indexed in Scilit:

• A calcium channel mutation causing hypokalemic periodic paralysis
  Human Molecular Genetics, 1994
• Calcium channel β-subunit binds to a conserved motif in the I–II cytoplasmic linker of the α1-subunit
  Nature, 1994
• Localization of the Gene Encoding the α2/δ Subunit (CACNL2A) of the Human Skeletal Muscle Voltage-Dependent Ca2+ Channel to Chromosome 7q21-q22 by Somatic Cell Hybrid Analysis
  Genomics, 1994
• Identification of 1,4‐dihydropyridine binding domains within the primary structure of the α₁ subunit of the skeletal muscle L‐type calcium channel
  FEBS Letters, 1993
• Genetic mapping of the β1- and γ-subunits of the human skeletal muscle L-type voltage-dependent calcium channel on chromosome 17q and exclusion as candidate genes for malignant hyperthermia susceptibility
  Human Molecular Genetics, 1993
• Exclusion of malignant hyperthermia susceptibility (MHS) from a putative MHS2 locus on chromosome 17q and of the α1, β1, and γ subunits of the dihydropyridine receptor calcium channel as candidates for the molecular defect
  Human Molecular Genetics, 1993
• Assignment of the Human Gene for the β Subunit of the Voltage-Dependent Calcium Channel (CACNLB1) to Chromosome 17 Using Somatic Cell Hybrids and Linkage Mapping
  Genomics, 1993
• Adult muscle sodium channel α-subunit is a gene candidate for malignant hyperthermia susceptibility
  Genomics, 1992
• Regions of the skeletal muscle dihydropyridine receptor critical for excitation–contraction coupling
  Nature, 1990
• Standardization of the Caffeine Halothane Muscle Contracture Test
  Anesthesia & Analgesia, 1989